Tourette syndrome (TS) is a disabling neuropsychiatric disorder characterised by persistent motor and vocal tics. TS is a highly comorbid state, hence, patients might experience anxiety, obsessions, compulsions, sleep abnormalities, depression, emotional liability, learning problems, and attention deficits in addition to tics. In spite of its complex heterogeneous genetic aetiology, recent studies highlighted a strong link between TS and genetic lesions in the HDC (L-histidine decarboxylase) gene, which encodes the enzyme that synthetises histamine, and the SLITRK1 (SLIT and TRK-like family member 1) gene, which encodes a transmembrane protein that was found to regulate neurite outgrowth. In addition to validating the contribution of a specific genetic aberration to the development of a particular pathology, animal models are crucial to dissect the function of disease-linked proteins, expose disease pathways through examination of genetic modifiers and discover as well as assess therapeutic strategies. Mice with a knockout of either Hdc or Slitrk1 exhibit anxiety and those lacking Hdc, display dopamine agonist-triggered stereotypic movements. However, the mouse knockouts do not spontaneously display tics, which are recognised as the hallmark of TS. In this review, we explore the features of the present genetic animal models of TS and identify reasons for their poor resemblance to the human condition. Importantly, we highlight ways forward aimed at developing a valuable genetic model of TS or a model that has good predictive validity in developing therapeutic drugs for the treatment of tics, hence potentially accelerating the arduous journey from lab to clinic.
INTRODUCTION
Tourette syndrome (TS) is a developmental neuropsychiatric disorder whereby afflicted patients suffer from chronic fluctuating motor and vocal tics. In view of its complex heterogeneous genetic aetiology, for decades, the specific genes involved remained elusive. Breaking the mould, recent studies were successful in identifying genetic lesions in two genes: L-histidine decarboxylase (HDC), which encodes the rate limiting enzyme in histamine biosynthesis [1] , and the SLIT and TRK-like family member 1 (SLITRK1), which encodes a transmembrane protein with strong homology to the axon guidance molecule, SLIT and the neurotrophin receptor, TRK [2] . These two emerging super candidates spurred the development of Slitrk1-knockout mice [3] and vigorous reanalysis of extensive data from previouslygenerated Hdc-knockouts [4] [5] [6] , with the aim of establishing a TS animal model. Both knockout mice are viable and although a shared characteristic is anxiety, which is a trait relevant to the features of TS, the models stop short of spontaneously displaying tics, that are recognised as the hallmark of TS.
Mouse models are critical in the study of human disease, primarily because they allow us to validate the contribution of a specific chromosomal or genetic aberration to the disease phenotype. Secondarily, animal models open the door to the use of a variety of tools to dissect the function of disorderlinked proteins, the uncovering of relevant disease pathways through the examination of genetic modifiers, and the discovery as well as the trialing of novel therapeutic strategies.
In this review we probe the state of the art with regards to TS genetic models, identify the hurdles and go back to the drawing board to identify new approaches and strategies to hasten the arduous trip from lab to clinic.
CLINICAL SPECTRUM OF TS
TS has a male predominance and although the typical onset is around the age of five, it often remains under-diagnosed [7] [8] [9] . World-wide prevalence is estimated between 0.3 and 1% [10, 11] . Tics often peak in severity between age 8 to 12 [12, 13] and significantly decline after puberty in 80% of the cases [14] . Tics, which are sudden, repetitive motor and vocal behaviours involving discrete muscle groups, can be simple or complex. Simple motor tics are any sudden, meaningless movements that recur in bouts, such as eye blinking, rapid head jerks and shoulder shrugs. Although any part of the body can be affected, the face, head and shoulders are the most common areas involved. Complex motor tics seem more purposeful but they are still sudden movements, which involve more than one muscle group, such as facial grimaces, touching others, or pivoting movements. Vocal tics typically begin after the onset of motor tics and involve simple sudden utterance of sounds such as throat clearing, sniffing or coughing. More complex forms of vocal tics can be repetitive, purposeless utterance of words, phrases or statements that are out of context and expression of obscenities (coprolalia) [9, 15] . The ability to suppress tics for brief intervals and, in most cases, the existence of premonitory sensory urges that are relieved by the execution of a tic, are features that differentiate TS from other movement disorders [15] .
TS is a highly comorbid state, hence, in addition to tics, patients might experience anxiety, obsessions, compulsions, sleep abnormalities, depression, emotional liability, learning problems, and attention deficits, which precipitate distress [16] [17] [18] . In childhood, the most frequent comorbid disorder with TS is attention-deficit hyperactivity disorder (ADHD), which causes behaviour hyperactivity, impulsiveness and problems with attention focusing [19] . Obsessive-compulsive disorder (OCD) is also very frequent in TS, and usually causes more significant distress and functional impairment than the tics themselves [20] .
The symptomatology of OCD is directed at reducing anxiety, is ritualized and changes little over time whereas tics are waxing and waning in course, are usually not dependent on anxiety, and involve fragmented movements. Both tics and obsessive-compulsive behaviours can be suppressed voluntarily and though worsened during periods of emotional excitement and fatigue, they plummet during periods that require focused attention and fine motor or vocal control [9, 21, 22] . Complex tics are usually difficult to distinguish from compulsions and in this context, TS and OCD are sometimes thought to be a common pathology with OCD being the mental form of TS and TS being the motor form of OCD [23] . Although these two disorders are diagnostically separate, aetiologically there is a common pattern including the involvement of similar brain areas in symptom manifestation [15, 20, 24] . If tics interfere with the daily life, antipsychotic agents, which reduce the symptoms but do not cure the disorder, are recommended [25, 26] .
In addition to pharmacological treatment, behavioural therapies and psychosocial interventions can also be effective [27] .
TS GENE DISCOVERY: CONTAINED EXCITEMENT?
A significant genetic contribution to TS was identified through twin studies, where concordance rates over 50% were observed in monozygotic twins in contrast to rates below 10% for dizygotic twins [28, 29] . Furthermore, TS family studies show a greater rate of TS or chronic tics in first-degree relatives compared to rates in relatives of controls [30] [31] [32] [33] . Initially thought to be a monogenic Mendelian disorder, TS is presently recognised as a complex disorder, with multiple genes interacting with various environmental factors to bring about the onset of symptoms. In this regard, several association studies assessing a variety of biologically plausible candidate genes as well as linkage screens were undertaken to underpin TS susceptibility loci [34] [35] [36] [37] . Although the results fell short of remarkable considering the lack of independent reproducibility, the recent discovery of two causal genes with a role in TS, albeit minor, has generated considerable excitement in the field. was found to regulate neurite outgrowth, a process that is inhibited in the absence of SLITRK1 phosphorylation [38] and the presence of the frameshift mutation [2] . Furthermore, 14-3-3 proteins, which are involved in a multitude of cellular processes, ranging from proliferation and differentiation to membrane excitability, were found to interact with SLITRK1 [38] . Several follow-up studies that screened for the observed SLITRK1 genetic changes in TS either failed to find them [39] [40] [41] [42] , or when identified, they did not segregate with the disorder in families [43, 44] , hence clouding the link between SLITRK1 and TS. In this context, the original authors rejected claims of confounding population stratification between cases and controls [45] , and recent studies by us and other groups have re-highlighted the significance of the initial findings by demonstrating a strong over-transmission of alleles and/or haplotypes of SLITRK1 to affected individuals [46] [47] [48] . All in all, there is a consensus that the TS gene discovery story has had a promising start.
Although mutations in the genes discovered are found in only a small fraction of affected persons, there is presently an impetus to delve into protein function as well as the mechanisms through which loss of function leads to TS.
In this regard, the next stop of the journey towards the clinic is definitely animal models.
MOUSE MODELS OF TS: TICKLISH QUESTIONS
What makes a valuable animal model of human disease? Considering, for instance, the paediatric neurological disease spinal muscular atrophy (SMA) [51] [52] [53] , we note that the underlying neurodegenerative pathology can be fully reproduced in an animal because: firstly, the aetiology, which involves a deficiency of the survival of motor neurons (SMN) protein, is clearly defined [54] ; secondly, the disease manifestations in mice are noticeable and quantifiable including decreased lifespan, motor neuron loss, atrophic muscle fibres as well as motor defects [55] [56] [57] [58] ; and, thirdly, such abnormalities can be relieved by therapies known to be effective in humans such as those that increase SMN levels [59] [60] [61] [62] . In the era preceding TS gene discovery, the animal model that by far exhibited the greatest behavioural similarities to TS is the D1 receptor cholera toxin (D1CT-7) transgenic mouse [63, 64] . This model has corticallimbic hyperactivity triggered through the [65, 66] , Slitrk1-null mice had no compulsive and/or tic-related behaviours, a result that was unexpected given that in addition to TS, SLITRK1 has also been linked to TTM [2, 67] , which like TS is believed to belong to the OCD spectrum.
Hdc-knockout mice are not able to produce histamine and, hence, lack histamine-dependent activation through histamine receptors. Hdc was originally implicated in TS because it neighboured a chromosomal inversion that was hypothesised to influence SLITRK1 expression pattern and levels [2] . Furthermore, In Hdc -/-mice, the targeting vector replaces exons 6-8 (and part of exon9) and a truncated protein similar to the one described in patients could be produced. Mice exhibit anxiety and tics that are not spontaneous but dopamine agonist-induced. Alteration of the PLP domain has a negative impact on the binding of pyridoxal 5'-phosphate, an essential coenzyme for HDC activity. aa -amino acids.
need to be done to prove these hypotheses.
The absence of TS-like behaviours in mice with a genetic lesion which is similar to that described in patients with TS would certainly raise questions about the causative link between HDC and TS. 
CONCLUSIONS

